Literature DB >> 2497797

Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles.

J Milhaud1, M A Hartmann, J Bolard.   

Abstract

The interaction of the polyene antibiotic amphotericin B (AmB) (Fig. 1) with large unilamellar vesicles (LUV) was monitored by circular dichroism (CD) and carboxyfluorescein (CF) release. LUV afford a far better model for biological membranes than small unilamellar vesicles (SUV) which have been used until now. With dimyristoyl phosphatidyl choline (DMPC) LUV (i.e., containing saturated acyl chains), a strong and not saturable binding for AmB/lipid ratios up to 0.5 was observed both above and below the phase transition temperature. Incorporation of cholesterol into the vesicles did not significantly change the interaction. With egg PC (EPC) LUV (i.e., containing unsaturated acyl chains), quite a different picture emerged: the binding reached saturation for AmB/lipid ratios of about 5 x 10(-3), a result not observed with EPC SUV. When sterols were introduced into membranes, the CD spectral features obtained in the presence of ergosterol were different from those obtained in the presence of cholesterol. Such a different behavior was not observed with SUV. We suggest that species whose CD spectrum was observed after 15 min in the presence of ergosterol-containing EPC LUV is the particular one which forms wide channels and induces a Ca2+ release. (H. Ramos, A. Attias, B.E. Cohen and J. Bolard, submitted for publication). The CF release from EPC LUV induced by AmB was very low, even at very high concentrations of the antibiotic (3 x 10(-4)M). In contrast, an important release of the fluorescent dye was observed with DMPC LUV at concentrations of approximately 10(-5)M.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497797     DOI: 10.1016/0300-9084(89)90130-2

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

Review 1.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Enhanced action of amphotericin B on Leishmania mexicana resulting from heat transformation.

Authors:  H Ramos; J Milhaud; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 3.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities.

Authors:  Daniel S Palacios; Ian Dailey; David M Siebert; Brandon C Wilcock; Martin D Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

5.  Cooperative partition model of nystatin interaction with phospholipid vesicles.

Authors:  Ana Coutinho; Manuel Prieto
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

6.  Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation.

Authors:  Ana Coutinho; Liana Silva; Alexander Fedorov; Manuel Prieto
Journal:  Biophys J       Date:  2004-08-17       Impact factor: 4.033

7.  Salvage treatment with amphotericin B in progressive human alveolar echinococcosis.

Authors:  Stefan Reuter; Andreas Buck; Olaf Grebe; Karin Nüssle-Kügele; Peter Kern; Burkhard J Manfras
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

8.  Effect of amphotericin B on larval growth of Echinococcus multilocularis.

Authors:  Stefan Reuter; Marion Merkle; Klaus Brehm; Peter Kern; Burkhard Manfras
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

9.  Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.

Authors:  P Legrand; E A Romero; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

10.  An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety.

Authors:  Armando Antillón; Alexander H de Vries; Marcel Espinosa-Caballero; José Marcos Falcón-González; David Flores Romero; Javier González-Damián; Fabiola Eloísa Jiménez-Montejo; Angel León-Buitimea; Manuel López-Ortiz; Ricardo Magaña; Siewert J Marrink; Rosmarbel Morales-Nava; Xavier Periole; Jorge Reyes-Esparza; Josué Rodríguez Lozada; Tania Minerva Santiago-Angelino; María Cristina Vargas González; Ignacio Regla; Mauricio Carrillo-Tripp; Mario Fernández-Zertuche; Lourdes Rodríguez-Fragoso; Iván Ortega-Blake
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.